Presented at #ESCCongress:
Among 16,808 adults without known cardiovascular disease, silent atherosclerosis was present in 57.1%, was detectable in early adulthood, and became more prevalent and extensive with age in a sex-dependent pattern. Full REACT trial results: https://t.co/KkNM5hC9RB
@escardio
The HHS Secretary told millions this week that the MMR vaccine contains fetal tissue. It doesn't. And that's one of several myths spreading right now, as measles does the same.
So let's go through them, one by one, with sources you can check yourself. ๐งต
Sunday: Iโll do a quick fact check of this insane RFK Jr interview
Monday: Iโm up to 40 lies & it was only a 3 min clip!
Tuesday: Ready to defend my 2nd PhD thesis on fascist quackery
That's why @SaveAmericaMvm & I are holding him accountable
https://t.co/MDVvksCDSs
Yes! Journal club!
Our latest video in partnership with @DGlaucomflecken summarizes the B-Well 1 and B-Well 2 trials investigating bepirovirsen therapy for chronic hepatitis B virus infection. Read the full study for free: https://t.co/iw6ymD4ukJ
#hepatology
Dude, Phil, you canโt out-study Infectious Disease. Donโt even try.
Our latest video in our partnership with @DGlaucomflecken summarizes the AZ-SWED trial that evaluated whether a 5-day course of azithromycin decreases the severity of illness in young children with wheezing. Read the full study for free: https://t.co/IVSVr2VqAA
#pediatrics
Sign up now for the next @NEJM_AI free virtual event: Value Alignment & Incentive Divergence in Clinical AI
As AI becomes embedded in clinical decision-making, different models prioritize decisions in different ways. What does that mean for patients, clinicians, and health systems?
Learn more and sign up: https://t.co/6adPxGtScx
๐๐จ๐ฐ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐ข๐ง ๐ต๐ฌ๐ฑ๐ด ๐ฌ๐๐๐ ๐๐๐๐!
A new Public Health Alerts report, published in partnership with @CIDRAP: Tobacco Product Use among U.S. Adults, 2023โ2024 https://t.co/1FOVMrDTrx
Hey look! @nejm moved my writing to a new spot.
Here's the first post, a rant about a particularly annoying requirement for those of us in work in hospitals
(link below)
1/3
Sonja A. Rasmussen, MD, discusses the 2025โ2026 influenza season, including factors contributing to the intensity of influenza activity. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/ZoOLQZ0zmF
"We are bearing witness to what fear can do to the health of a community"
A poignant piece @NEJM about the Minneapolis devastation
"We care for our patients because they are human beings. Our patients are being harmed. People are dying unnecessarily."
https://t.co/owirHJTwqQ
@NEJM Honored that our work on gene-edited pig kidney xenotransplantation was selected as one of NEJMโs Notable Articles of 2025. Grateful to our incredible team @mgh_transplant @MGH_Kidneys and patients who made this milestone possible.
๐ https://t.co/s03VYoeXC6
#Xenotransplant@NEJM
Humbled: @arjunmanrai@tabuckley_ to be in Harvard Medical School's Top Science News of 2025 for their AI contributions and the enigmatic, cybernetic Dr. CaBot making its debut as discussant of Case Records of the Massachusetts General Hospital @NEJM https://t.co/VzvyvwQIR5
NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD (@BageLeMage), talks about a new study on using cap-refill time to manage resuscitation in septic shock. Read the full summary and comment from Dr. Daniel Dressler: https://t.co/0trlSZHHPC
Also in this week's issue of NEJM Clinician:
Unprovoked VTE: Should Patients Continue Oral Anticoagulants Beyond 90 Days? https://t.co/Jox4bnDajT
Partial vs. Total Knee Arthroplasty: Long-Term Results https://t.co/3LzS1MwYMp
Variability in PSA Levels During Prostate Cancer Screening https://t.co/Wtg4LIs2Z4
For hospitalized patients with community-acquired pneumonia, glucocorticoids have been proposed as adjunctive therapy, but recent data on their benefits have been conflicting. Research findings from the SONIA trial are summarized in a new Quick Take video. https://t.co/374wIwG3MA
A new article in @nejmcatalyst reports the results of a pilot randomized controlled trial exploring the link between receiving a preferred safety device and a change in firearm-storage behavior. The results suggest that the Penn Medicine program that distributes free firearm locking devices to patients may contribute to increased adherence to gun safety practices.
Learn more in "Encouraging and Measuring Secure Firearm Storage: A Scalable Hospital-Driven Program," a new article in NEJM Catalyst Innovations in Care Delivery: https://t.co/kZTIiZrmJ8
Case Record of the Massachusetts General Hospital (@MassGeneralNews): A 27-year-old man was admitted to the medical service of this hospital because of abnormal behaviors and confusion.
The patient had been in his usual state of health until 2 months before the current presentation, when his family and outpatient mental health providers noticed abnormal behaviors and an increasing amount of paranoia and confusion after he had independently discontinued his medications prescribed to treat bipolar I disorder. The patient was noted to have repeatedly called his mother; he reported being persecuted, and his mother stated that he had been speaking in nonsensical, cryptic statements. The patient had no recollection of their conversation shortly after each phone call. On the day of admission, the patient became agitated upon trying to sleep, asking for the noise generated by the crickets outside to be silenced, and his partner brought him to the emergency department of this hospital for evaluation.
Read the full case details in โA 27-Year-Old Man with Abnormal Behaviors, Confusion, and Seizure,โ a Case Record of the Massachusetts General Hospital, by N.V. Quijije et al., from Massachusetts General Hospital (@MassGeneralNews) and @harvardmed: https://t.co/7vm6h4Hf2i
Beyond proud today โ my son Joshua Wischmeyer is first author on a New England Journal of Medicine paper! ๐๐ @NEJM
Josh is a junior pre-med at @DavidsonCollege, yet already publishing groundbreaking work in genetics + hemophilia. ๐๐
๐ Childrenโs Hospital Colorado write-up:
https://t.co/dtvcHah5sS
๐ NEJM paper:
https://t.co/YEbjouQbUh
So proud of you, Josh.
In patients with CKD, SGLT2 inhibitors significantly reduced left ventricular mass compared to placebo. This was consistent across subgroups including baseline cardiovascular disease or etiology of kidney disease. Full DECODE-CKD trial results: https://t.co/UZvHJetjv0